search
Back to results

Effects of Electrostimulation on Glycemic Control in Obesity (ElectrOBA)

Primary Purpose

Obesity Adult Onset

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Muscle Electrostimulation
Sponsored by
Fondation Ildys
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity Adult Onset focused on measuring muscle electrostimulation, diabetes, endocrinology, physical activity, quality of life, obesity

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • men and women over 18 years old and under 70 years old
  • with severe or morbid obesity (BMI> = 35)
  • with or without bariatric surgery
  • able to understand and respect the protocol and its requirement
  • who signed the consent prior to any other procedure protocol

Exclusion Criteria:

  • major patients under guardianship / curatorship / legal protection
  • pregnant patients
  • patients with epilepsy
  • with an implanted electronic/electrical device (cardiac pacemaker, intracardiac defibrillator, etc.)
  • with a baclofen pump
  • suffering from serious disorders of the arterial circulation in the lower limbs such as Peripheral Arterial Obstructive Disease (PAOD)
  • suffering from abdominal or inguinal hernia
  • suffering from cardiac arrhythmia
  • suffering from skin lesions and/or infections foci on one or more areas where the electrodes are placed
  • suffering from sensory disorders in the areas of stimulation
  • patients unable to complete the entire program

Sites / Locations

  • CF Center - Fondation Ildys Site de Perharidy

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group

Electrostimulation group

Arm Description

Patients benefiting only from the usual nutritional rehabilitation program G1a: diabetic patients G1b: non-diabetic patients

Patients benefiting from the usual program AND muscle electrostimulation sessions G2a: diabetic patients G2b: non-diabetic patients

Outcomes

Primary Outcome Measures

Carbohydrate balance
Evaluation of the time spent (%) above / in / below the patient's glycemic targets measured with a "Free Style" glycemic holter

Secondary Outcome Measures

Homa Index
Insulin resistance assessment
Quicki Index
Insulin sensitivity assessment
Blood Glucose Levels
Evaluation of the glucose levels (average, minimum, maximum)
Postprandial blood glucose
Assessment of the number of postprandial hyper and hypoglycemia
Basal blood metabolism
Blood chemistry analysis (lipid balance)
Impedance
Bioelectrical impedance analysis of body composition
Maximal voluntary force
Measurement of the maximum voluntary strength and endurance of the quadriceps
Six-minutes walk test (6MWT)
Measurement of the distance traveled during the 6MWT
"Ricci & Gagnon" questionnaire
Assessment of the level of physical activities and sedentary lifestyle
Adherence to the rehabilitation program
Evaluation of the number of performed sessions compared to the expected for the proposed activities (collective balneotherapy, individual balneotherapy, supervised adapted physical activities, independent nordic walking) with analysis of the reasons for the differences
Anthropometry
Weight (Kg) and height (cm) will be combined to report BMI in kg/m2
Quality of life, obesity and dietetics (QOLOD) rating scale
Evaluation of quality of life - This scale gives 5 sub-scores ranging from 0 (worse outcome) to 100 (better outcome) for each explored dimension.
Visual analog pain scale
Assessment of pain intensity during MES sessions with a visual analog scale
MES sessions check
Record of session criteria (duration, program, maximum intensity, contraction Y/N)

Full Information

First Posted
October 29, 2020
Last Updated
September 12, 2023
Sponsor
Fondation Ildys
Collaborators
Lille Catholic University
search

1. Study Identification

Unique Protocol Identification Number
NCT04643899
Brief Title
Effects of Electrostimulation on Glycemic Control in Obesity
Acronym
ElectrOBA
Official Title
Evaluation of the Effects of Electrical Muscle Stimulation on Carbohydrate Homeostasis in Adult Patients With Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
March 29, 2021 (Actual)
Primary Completion Date
March 1, 2023 (Actual)
Study Completion Date
July 19, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Ildys
Collaborators
Lille Catholic University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluate the effects of muscle electrostimulation (MES) on carbohydrate homeostasis in adult patients with obesity. Its aims are also to evaluate the tolerance of feasibilty and the tolerance of MES and the impact on basal metabolism ; muscle mass (maintenance, gain or loss) in a context of calorie restriction ; physical capacities ; adherence to the usual rehabilitation program ; eating behavior : quality of life.
Detailed Description
Prevalence of adult obesity in general french population (≈15%) justifies the implementation of innovative care. Prescribing regular physical activity is one of the recommendations for managing obesity. However, patients find it difficult because of non-adapted offered activities; non-achievement concrete results despite the effort; difficulties to manage activities and to plan objective. Situation is seen as a failure and discourages patients. In addition, the obese patient may suffer from orthopedic disorders, cardiovascular contraindications, and the excessive weight in itself may force him to become sedentary. The recommendations on the practice of physical activity in the overall management of obesity are therefore not always applicable. Muscle electrostimulation (MES) could therefore be an interesting additional tool in the management of obesity and particularly of glycemic control in obese patients suffering from type 2 diabetes. Studies are still relatively few and present certain limits (small samples, short period of MES, very specific populations, few parameters evaluated, lack of consensus on the methods of MES, etc.). The results are nevertheless encouraging and call for the implementation of additional studies. Investigators therefore propose a controlled, randomized, single-center study in a group of 60 adult patients suffering from severe or morbid obesity (BMI> = 35) in a 3-week rehabilitation stay. The aims are to establish whether MES is a possible and interesting tool in the management of obesity, by checking the following hypotheses: control of carbohydrate metabolism is better when a MES is implemented; MES sessions improve patients' physical capacities and / or their tolerance to exercise; MES improves the quality of life of patients; MES improves patient adherence to the usual nutritional rehabilitation program; MES sessions are well tolerated and the accepted intensity nevertheless guarantees sufficient muscle stimulation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity Adult Onset
Keywords
muscle electrostimulation, diabetes, endocrinology, physical activity, quality of life, obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Monocentric; prospective; opened ; randomized; controlled study Distribution of patients in groups according to a ratio (1: 1)
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Patients benefiting only from the usual nutritional rehabilitation program G1a: diabetic patients G1b: non-diabetic patients
Arm Title
Electrostimulation group
Arm Type
Experimental
Arm Description
Patients benefiting from the usual program AND muscle electrostimulation sessions G2a: diabetic patients G2b: non-diabetic patients
Intervention Type
Device
Intervention Name(s)
Muscle Electrostimulation
Other Intervention Name(s)
Compex Pro Rehab ®, 253311x - REF 201010
Intervention Description
Scheduled sessions of 20 minutes per day; 5 days a week In physiotherapy or in their room for the most dependent patients Installation and monitoring by a physiotherapist or by the trained clinical research nurse Modalities: Device program n ° 1: 20mn (2mn of warm-up, 15mn of work at 75hz, then 3mn of recovery) 4 electrodes (2 per thigh): large model (5 * 10 cm) for better comfort - Dura-Stick Plus model (reference 42200) Gradual auto-increase of the intensity to the highest possible value tolerated, nevertheless allowing a contraction
Primary Outcome Measure Information:
Title
Carbohydrate balance
Description
Evaluation of the time spent (%) above / in / below the patient's glycemic targets measured with a "Free Style" glycemic holter
Time Frame
Continuous measurement over the entire stay (Day 1 to Day 21)
Secondary Outcome Measure Information:
Title
Homa Index
Description
Insulin resistance assessment
Time Frame
Change from baseline (Day 1) to week 3 (Day 21)
Title
Quicki Index
Description
Insulin sensitivity assessment
Time Frame
Change from baseline (Day 1) to week 3 (Day 21)
Title
Blood Glucose Levels
Description
Evaluation of the glucose levels (average, minimum, maximum)
Time Frame
Continuous measurement over the entire stay (Day 1 to Day 21)
Title
Postprandial blood glucose
Description
Assessment of the number of postprandial hyper and hypoglycemia
Time Frame
Continuous measurement over the entire stay (Day 1 to Day 21)
Title
Basal blood metabolism
Description
Blood chemistry analysis (lipid balance)
Time Frame
Change from baseline (Day 2) to week 3 (Day 21)
Title
Impedance
Description
Bioelectrical impedance analysis of body composition
Time Frame
Change from baseline (Day 2) to week 3 (Day 20)
Title
Maximal voluntary force
Description
Measurement of the maximum voluntary strength and endurance of the quadriceps
Time Frame
Change from baseline (Day 2) to week 3 (Day 21)
Title
Six-minutes walk test (6MWT)
Description
Measurement of the distance traveled during the 6MWT
Time Frame
Change from baseline (Day 1) to week 3 (Day 20)
Title
"Ricci & Gagnon" questionnaire
Description
Assessment of the level of physical activities and sedentary lifestyle
Time Frame
Change from baseline (Day 2) to week 3 (Day 21)
Title
Adherence to the rehabilitation program
Description
Evaluation of the number of performed sessions compared to the expected for the proposed activities (collective balneotherapy, individual balneotherapy, supervised adapted physical activities, independent nordic walking) with analysis of the reasons for the differences
Time Frame
Evaluation at each sessions from Day 1 to Day 21
Title
Anthropometry
Description
Weight (Kg) and height (cm) will be combined to report BMI in kg/m2
Time Frame
Change from baseline (Day 1) to week 3 (Day 21)
Title
Quality of life, obesity and dietetics (QOLOD) rating scale
Description
Evaluation of quality of life - This scale gives 5 sub-scores ranging from 0 (worse outcome) to 100 (better outcome) for each explored dimension.
Time Frame
Change from baseline (Day 1) to week 3 (Day 21)
Title
Visual analog pain scale
Description
Assessment of pain intensity during MES sessions with a visual analog scale
Time Frame
Evaluation at each sessions from Day 2 to Day 20
Title
MES sessions check
Description
Record of session criteria (duration, program, maximum intensity, contraction Y/N)
Time Frame
Change from baseline (Day 1) to week 3 (Day 21)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: men and women over 18 years old and under 70 years old with severe or morbid obesity (BMI> = 35) with or without bariatric surgery able to understand and respect the protocol and its requirement who signed the consent prior to any other procedure protocol Exclusion Criteria: major patients under guardianship / curatorship / legal protection pregnant patients patients with epilepsy with an implanted electronic/electrical device (cardiac pacemaker, intracardiac defibrillator, etc.) with a baclofen pump suffering from serious disorders of the arterial circulation in the lower limbs such as Peripheral Arterial Obstructive Disease (PAOD) suffering from abdominal or inguinal hernia suffering from cardiac arrhythmia suffering from skin lesions and/or infections foci on one or more areas where the electrodes are placed suffering from sensory disorders in the areas of stimulation patients unable to complete the entire program
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lena SEITE, MD
Organizational Affiliation
Fondation Ildys
Official's Role
Principal Investigator
Facility Information:
Facility Name
CF Center - Fondation Ildys Site de Perharidy
City
Roscoff
ZIP/Postal Code
29684
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23368829
Citation
Grosset JF, Crowe L, De Vito G, O'Shea D, Caulfield B. Comparative effect of a 1 h session of electrical muscle stimulation and walking activity on energy expenditure and substrate oxidation in obese subjects. Appl Physiol Nutr Metab. 2013 Jan;38(1):57-65. doi: 10.1139/apnm-2011-0367. Epub 2012 Nov 12.
Results Reference
background
PubMed Identifier
25734937
Citation
van Buuren F, Horstkotte D, Mellwig KP, Frund A, Vlachojannis M, Bogunovic N, Dimitriadis Z, Vortherms J, Humphrey R, Niebauer J. Electrical Myostimulation (EMS) Improves Glucose Metabolism and Oxygen Uptake in Type 2 Diabetes Mellitus Patients--Results from the EMS Study. Diabetes Technol Ther. 2015 Jun;17(6):413-9. doi: 10.1089/dia.2014.0315. Epub 2015 Mar 3.
Results Reference
background
PubMed Identifier
25107502
Citation
Joubert M, Metayer L, Prevost G, Morera J, Rod A, Cailleux A, Parienti JJ, Reznik Y. Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot study. Acta Diabetol. 2015 Apr;52(2):285-91. doi: 10.1007/s00592-014-0636-5. Epub 2014 Aug 9.
Results Reference
background
PubMed Identifier
22296854
Citation
Miyamoto T, Fukuda K, Kimura T, Matsubara Y, Tsuda K, Moritani T. Effect of percutaneous electrical muscle stimulation on postprandial hyperglycemia in type 2 diabetes. Diabetes Res Clin Pract. 2012 Jun;96(3):306-12. doi: 10.1016/j.diabres.2012.01.006. Epub 2012 Jan 30.
Results Reference
background
PubMed Identifier
28194410
Citation
Vivodtzev I, Maffiuletti NA, Borel AL, Grangier A, Wuyam B, Tamisier R, Pepin JL. Acute Feasibility of Neuromuscular Electrical Stimulation in Severely Obese Patients with Obstructive Sleep Apnea Syndrome: A Pilot Study. Biomed Res Int. 2017;2017:3704380. doi: 10.1155/2017/3704380. Epub 2017 Jan 17.
Results Reference
background
Links:
URL
https://www.sraenutrition.fr/wp-content/uploads/2021/08/Enquete-epidemiologique-sur-le-suproids-et-lobesite-Odoxa-x-Obepi.pdf
Description
National survey (France) on obesity and overweight

Learn more about this trial

Effects of Electrostimulation on Glycemic Control in Obesity

We'll reach out to this number within 24 hrs